David J Rosa - 21 Apr 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role: EVP Chief Strategy & Growth Of
Signature: By: Donna Spinola For: Rosa, David J
Issuer symbol: ISRG
Transactions as of: 21 Apr 2023
Net transactions value: -$19,746,855
Form type: 4
Filing time: 24 Apr 2023, 21:37:15 UTC
Previous filing: 01 Mar 2023
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISRG	Common Stock	Options Exercise	$2,302,382	+54,000	+42%	$42.64^*	183,276	21 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$12,155,173	-40,800	-22%	$297.92	142,476	21 Apr 2023	Direct	F1, F2
transaction	ISRG	Common Stock	Options Exercise	$2,302,382	+54,000	+38%	$42.64^*	196,476	24 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$12,196,446	-40,764	-21%	$299.20	155,712	24 Apr 2023	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-54,000	-50%	$0.000000	54,000	21 Apr 2023	Common Stock	54,000	$42.64	Direct	F1, F4
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-54,000	-100%	$0.000000^*	0	24 Apr 2023	Common Stock	54,000	$42.64	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 15, 2023.
F2	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.54 to $299.47 as follows: 9,698 shares sold at $296.54 to $297.54; 25,403 shares sold at $297.55 to $298.53; and 5,699 shares sold at $298.60 to $299.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $297.79 to $301.83 as follows: 10,560 shares sold at $297.79 to $298.78; 28,240 shares sold at $298.84 to $299.84; 1,364 shares sold at $299.99 to $300.50; and 600 shares sold at $301.83. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.